- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有134家主力机构披露2025-06-30报告期持股数据，持仓量总计5.07亿股，占流通A股26.95%
- 波段诊断：
-
技术面诊股
诊断结果：6.1技术面打败了34%的股票
技术面评分前10的股票
近期的平均成本为4.68元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为4.68元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"4.68","date":1757922977,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.09.16","stock":"-0.43","trade":"-0.09","ind":"0.45"},{"date":"2025.09.15","stock":"-1.01","trade":"-0.14","ind":"0.63"},{"date":"2025.09.12","stock":"-0.20","trade":"0.60","ind":"-0.43"},{"date":"2025.09.11","stock":"0.00","trade":"0.29","ind":"3.36"},{"date":"2025.09.10","stock":"-0.60","trade":"-0.63","ind":"0.38"},{"date":"2025.09.09","stock":"0.20","trade":"-1.92","ind":"-1.23"},{"date":"2025.09.08","stock":"1.43","trade":"0.35","ind":"0.61"},{"date":"2025.09.05","stock":"0.41","trade":"1.70","ind":"3.89"},{"date":"2025.09.04","stock":"-0.61","trade":"-1.03","ind":"-2.83"},{"date":"2025.09.03","stock":"-0.81","trade":"-0.44","ind":"-0.65"},{"date":"2025.09.02","stock":"-1.20","trade":"-1.31","ind":"-2.14"},{"date":"2025.09.01","stock":"1.83","trade":"2.44","ind":"1.05"},{"date":"2025.08.29","stock":"1.23","trade":"0.69","ind":"0.99"},{"date":"2025.08.28","stock":"0.41","trade":"-0.58","ind":"2.25"},{"date":"2025.08.27","stock":"-2.41","trade":"-3.21","ind":"-1.43"},{"date":"2025.08.26","stock":"0.40","trade":"-1.06","ind":"0.26"},{"date":"2025.08.25","stock":"0.61","trade":"1.51","ind":"2.26"},{"date":"2025.08.22","stock":"-3.34","trade":"-0.05","ind":"2.07"},{"date":"2025.08.21","stock":"1.60","trade":"-0.62","ind":"-0.06"},{"date":"2025.08.20","stock":"10.11","trade":"-0.76","ind":"0.89"},{"date":"2025.08.19","stock":"0.44","trade":"0.49","ind":"-0.12"}]
华邦健康,深证成指,化学制药指数
压力支撑
该股压力位为4.68元，支撑位为4.62元。
[{"text":"\u538b\u529b\u4f4d","value":"4.68","date":1757952000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.62","date":1757952000,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.6资金面打败了1%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月16日 20:30
| 机构今日流向(万元) | -1753.04 | 机构5日流向(万元) | -4758.50 |
| 机构10日流向(万元) | -12362.63 | 机构20日流向(万元) | -30267.53 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少255.84万股，其中基金净减仓7家，主力净减仓41家，请投资者中长期谨慎为宜。
截止2025-06-30，共134家主力机构（基金130家，一般法人4家），持仓量总计50701.06万股，占流通A股26.95%
其中，基金持仓与2024-12-31相比：
增仓：40家 ，增持 1329.31万股
减仓：47家 ，减持 651.34万股
新出现在主力名单中：44家 ，持有37429.62万股
从主力名单中消失：85家 ，原持有38700.35万股
其中，基金持仓与2024-12-31相比：
增仓：40家 ，增持 1329.31万股
减仓：47家 ，减持 651.34万股
新出现在主力名单中：44家 ，持有37429.62万股
从主力名单中消失：85家 ，原持有38700.35万股
消息面诊股
诊断结果：6.3消息面打败了84%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华邦健康：9月15日获融资买入998.55万元
2025-09-16 - 华邦健康：9月12日获融资买入1924.83万元
2025-09-15 - 华邦健康：9月11日获融资买入2332.66万元，
2025-09-12 - 华邦健康：9月10日获融资买入2016.23万元
2025-09-11 - 华邦健康：9月9日获融资买入1195.43万元，占
2025-09-10 - 华邦健康：公司目前合计持有颖泰生物47.70%股权
2025-09-09 - 华邦健康：普瑞金已完成北交所上市辅导备案
2025-09-09 - 华邦健康：9月8日获融资买入2242.67万元，占
2025-09-09 - 华邦健康：颖泰生物在公司合并报表范围内
2025-09-09 - 华邦健康：谱新生物搭建了细胞药物专用的核酸平台
2025-09-09
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-27 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-20 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-08-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-07 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-04 |
| 一般消息 | 高管变动 | 公司取消监事会 | 2025-05-14 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-25 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：5.8行业面打败了70%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.09.16","price":"0.45","value":"-0.09"},{"date":"2025.09.15","price":"0.63","value":"-0.14"},{"date":"2025.09.12","price":"-0.43","value":"0.60"},{"date":"2025.09.11","price":"3.36","value":"0.29"},{"date":"2025.09.10","price":"0.38","value":"-0.63"},{"date":"2025.09.09","price":"-1.23","value":"-1.92"},{"date":"2025.09.08","price":"0.61","value":"0.35"},{"date":"2025.09.05","price":"3.89","value":"1.70"},{"date":"2025.09.04","price":"-2.83","value":"-1.03"},{"date":"2025.09.03","price":"-0.65","value":"-0.44"},{"date":"2025.09.02","price":"-2.14","value":"-1.31"},{"date":"2025.09.01","price":"1.05","value":"2.44"},{"date":"2025.08.29","price":"0.99","value":"0.69"},{"date":"2025.08.28","price":"2.25","value":"-0.58"},{"date":"2025.08.27","price":"-1.43","value":"-3.21"},{"date":"2025.08.26","price":"0.26","value":"-1.06"},{"date":"2025.08.25","price":"2.26","value":"1.51"},{"date":"2025.08.22","price":"2.07","value":"-0.05"},{"date":"2025.08.21","price":"-0.06","value":"-0.62"},{"date":"2025.08.20","price":"0.89","value":"-0.76"},{"date":"2025.08.19","price":"-0.12","value":"0.49"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 百济神州 | 34.89% | -2.05% | 5.1分 |
| 2 | 向日葵 | 25.57% | 7.59% | 5.5分 |
| 3 | 华纳药厂 | 24.12% | 15.29% | 6.7分 |
| 4 | 艾力斯 | 23.18% | -3.99% | 5.7分 |
| 5 | 通化金马 | 18.39% | 13.89% | 6.2分 |
| 6 | 德展健康 | 14.77% | 12.32% | 6.2分 |
| 8 | 百利天恒 | 14.19% | -1.32% | 5.2分 |
| 10 | 恩华药业 | 13.46% | 6.54% | 6.4分 |
| 12 | 恒瑞医药 | 12.09% | -2.73% | 6.8分 |
| 14 | 多瑞医药 | 8.98% | -0.21% | 6.0分 |
| 16 | 金城医药 | 7.75% | -6.98% | 5.5分 |
| 18 | 华邦健康 | 7.59% | -2.30% | 5.2分 |
| 20 | 海翔药业 | 6.37% | 5.17% | 5.8分 |
| 22 | 富祥药业 | 5.63% | 7.16% | 5.6分 |
| 24 | 新和成 | 5.01% | -1.42% | 6.0分 |
| 26 | 信立泰 | 4.35% | -5.59% | 5.8分 |
| 28 | 司太立 | 2.31% | 2.40% | 6.2分 |
| 30 | 莎普爱思 | 2.18% | -0.24% | 6.2分 |
| 32 | ST景峰 | 1.22% | 1.22% | 5.1分 |
| 34 | 新华制药 | 0.96% | 3.19% | 6.4分 |
| 36 | 健康元 | 0.62% | -2.20% | 4.9分 |
| 38 | 本立科技 | 0.17% | 0.21% | 5.9分 |
| 40 | 国邦医药 | -0.61% | -4.00% | 5.4分 |
| 42 | 盟科药业 | -0.75% | 1.92% | 5.2分 |
| 44 | 泽璟制药 | -0.81% | -10.55% | 5.1分 |
| 46 | 金陵药业 | -0.97% | -0.83% | 6.0分 |
| 48 | 丽珠集团 | -1.18% | -0.67% | 5.8分 |
| 50 | *ST三圣 | -1.67% | -2.28% | 4.0分 |
| 52 | 康芝药业 | -1.93% | 8.56% | 6.3分 |
| 54 | 小方制药 | -1.99% | 0.70% | 6.5分 |
| 56 | 科伦药业 | -2.15% | -5.82% | 4.5分 |
| 58 | 华仁药业 | -2.79% | 2.05% | 6.2分 |
| 60 | 北大医药 | -2.94% | -1.72% | 5.5分 |
| 62 | 纳微科技 | -3.07% | -1.04% | 6.4分 |
| 64 | 海普瑞 | -3.54% | -1.16% | 6.2分 |
| 66 | 东亚药业 | -3.72% | 1.15% | 6.0分 |
| 68 | 常山药业 | -4.04% | 0.08% | 4.9分 |
| 70 | 海欣股份 | -4.13% | 3.42% | 6.3分 |
| 72 | 广济药业 | -4.33% | -1.92% | 5.9分 |
| 74 | 卫信康 | -4.73% | -2.92% | 5.7分 |
| 76 | 科源制药 | -4.87% | -0.78% | 5.8分 |
| 78 | 汉商集团 | -4.92% | 0.30% | 6.4分 |
| 80 | 海思科 | -5.58% | -3.74% | 5.7分 |
| 82 | 浙江医药 | -5.77% | -1.38% | 5.0分 |
| 84 | 尔康制药 | -5.84% | 2.11% | 5.8分 |
| 86 | 天新药业 | -6.11% | -1.38% | 5.5分 |
| 88 | 神奇制药 | -6.26% | 0.45% | 6.0分 |
| 90 | 誉衡药业 | -6.38% | 3.23% | 6.3分 |
| 92 | 华润双鹤 | -6.57% | -1.65% | 5.1分 |
| 94 | 亚虹医药 | -6.77% | -0.70% | 5.1分 |
| 96 | 民生健康 | -6.96% | 0.98% | 5.5分 |
| 98 | 仙琚制药 | -7.06% | -3.20% | 5.4分 |
| 100 | 赛分科技 | -7.21% | 1.73% | 5.4分 |
| 102 | 花园生物 | -7.38% | 0.49% | 5.4分 |
| 104 | 复旦张江 | -7.82% | 0.00% | 5.4分 |
| 106 | 拓新药业 | -8.33% | 0.67% | 5.1分 |
| 108 | 川宁生物 | -8.50% | -1.30% | 4.7分 |
| 110 | 双鹭药业 | -8.64% | -0.92% | 5.2分 |
| 112 | 华北制药 | -9.23% | -1.48% | 5.0分 |
| 114 | 莱美药业 | -9.67% | 3.32% | 5.7分 |
| 116 | 宣泰医药 | -10.08% | 1.55% | 5.7分 |
| 118 | 东诚药业 | -10.25% | 0.06% | 5.8分 |
| 120 | 圣诺生物 | -10.33% | 0.00% | 5.5分 |
| 122 | 哈三联 | -10.84% | -1.91% | 4.9分 |
| 124 | 威尔药业 | -11.31% | 0.32% | 6.1分 |
| 126 | 北陆药业 | -12.34% | 0.20% | 4.8分 |
| 128 | 益方生物 | -13.22% | 4.60% | 5.2分 |
| 130 | 亚太药业 | -13.83% | -1.42% | 5.1分 |
| 132 | 微芯生物 | -14.36% | -3.41% | 4.9分 |
| 134 | 一品红 | -15.64% | -11.97% | 4.7分 |
| 136 | 翰宇药业 | -17.33% | 0.67% | 5.1分 |
| 138 | 诚意药业 | -17.42% | 0.65% | 5.6分 |
| 140 | 上海谊众 | -19.35% | -0.33% | 4.8分 |
| 142 | 易明医药 | -20.13% | 1.35% | 5.3分 |
| 144 | 昂利康 | -21.18% | 5.80% | 5.1分 |
| 146 | 福元医药 | -24.42% | 1.53% | 5.6分 |
| 148 | 联环药业 | -26.67% | -3.14% | 5.2分 |
| 150 | 舒泰神 | -34.58% | -0.70% | 4.8分 |
| 152 | - | - | -38.25% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 56/226 ， 102/226。
[{"date":"2025-06-30","value":"4.07","vol":"1.40"},{"date":"2025-03-31","value":"1.95","vol":"-0.17"},{"date":"2024-12-31","value":"-3.08","vol":"19.77"},{"date":"2024-09-30","value":"4.47","vol":"4.61"},{"date":"2024-06-30","value":"3.12","vol":"3.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.07 | 1.95 | -3.08 | 4.47 | 3.12 |
| 行业(%) | 1.40 | -0.17 | 19.77 | 4.61 | 3.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"36.28","vol":"49.76"},{"date":"2025-03-31","value":"37.12","vol":"49.23"},{"date":"2024-12-31","value":"34.13","vol":"51.11"},{"date":"2024-09-30","value":"36.81","vol":"50.51"},{"date":"2024-06-30","value":"36.72","vol":"50.85"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
36.28 | 37.12 | 34.13 | 36.81 | 36.72 |
| 行业(%) | 49.76 | 49.23 | 51.11 | 50.51 | 50.85 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 57/226 ， 43/226。
[{"date":"2025-06-30","value":"0.39","vol":"79.06"},{"date":"2025-03-31","value":"-3.24","vol":"-0.84"},{"date":"2024-12-31","value":"0.60","vol":"17.88"},{"date":"2024-09-30","value":"0.64","vol":"45.69"},{"date":"2024-06-30","value":"0.91","vol":"710.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.39 | -3.24 | 0.60 | 0.64 | 0.91 |
| 行业(%) | 79.06 | -0.84 | 17.88 | 45.69 | 710.38 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"23.90","vol":"56.66"},{"date":"2025-03-31","value":"18.50","vol":"-21.21"},{"date":"2024-12-31","value":"-198.96","vol":"-21.14"},{"date":"2024-09-30","value":"-10.49","vol":"-32.33"},{"date":"2024-06-30","value":"-19.02","vol":"8.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
23.90 | 18.50 | -198.96 | -10.49 | -19.02 |
| 行业(%) | 56.66 | -21.21 | -21.14 | -32.33 | 8.14 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 68/226 ， 34/226。
[{"date":"2025-06-30","value":"0.20","vol":"0.21"},{"date":"2025-03-31","value":"0.10","vol":"0.10"},{"date":"2024-12-31","value":"0.39","vol":"0.43"},{"date":"2024-09-30","value":"0.29","vol":"0.33"},{"date":"2024-06-30","value":"0.19","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.10 | 0.39 | 0.29 | 0.19 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.71","vol":"1.32"},{"date":"2025-03-31","value":"0.78","vol":"0.67"},{"date":"2024-12-31","value":"3.12","vol":"3.24"},{"date":"2024-09-30","value":"2.23","vol":"2.18"},{"date":"2024-06-30","value":"1.45","vol":"1.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.71 | 0.78 | 3.12 | 2.23 | 1.45 |
| 行业(次) | 1.32 | 0.67 | 3.24 | 2.18 | 1.51 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 67/226 ， 49/226。
[{"date":"2025-06-30","value":"15.96","vol":"2.81"},{"date":"2025-03-31","value":"1.34","vol":"-28.76"},{"date":"2024-12-31","value":"26.84","vol":"-371.46"},{"date":"2024-09-30","value":"17.36","vol":"-9.87"},{"date":"2024-06-30","value":"8.50","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 15.96 | 1.34 | 26.84 | 17.36 | 8.50 |
| 行业 | 2.81 | -28.76 | -371.46 | -9.87 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.59","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.91","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.11","vol":"2.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.59 | - | 0.91 | - | 1.11 |
| 行业 | 1.73 | 0.00 | 1.99 | 0.00 | 2.19 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 57/226 ， 15/226。
[{"date":"2025-06-30","value":"1.23","vol":"3.66"},{"date":"2025-03-31","value":"1.14","vol":"3.59"},{"date":"2024-12-31","value":"1.08","vol":"3.32"},{"date":"2024-09-30","value":"1.11","vol":"3.66"},{"date":"2024-06-30","value":"1.05","vol":"3.59"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.23 | 1.14 | 1.08 | 1.11 | 1.05 |
| 行业 | 3.66 | 3.59 | 3.32 | 3.66 | 3.59 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.86","vol":"2.88"},{"date":"2025-03-31","value":"0.74","vol":"2.81"},{"date":"2024-12-31","value":"0.68","vol":"2.63"},{"date":"2024-09-30","value":"0.74","vol":"2.92"},{"date":"2024-06-30","value":"0.69","vol":"2.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.86 | 0.74 | 0.68 | 0.74 | 0.69 |
| 行业 | 2.88 | 2.81 | 2.63 | 2.92 | 2.88 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 17/226 ， 18/226。
[{"date":"2025-06-30","value":"46.17","vol":"33.92"},{"date":"2025-03-31","value":"47.30","vol":"34.04"},{"date":"2024-12-31","value":"47.46","vol":"34.34"},{"date":"2024-09-30","value":"47.03","vol":"33.02"},{"date":"2024-06-30","value":"47.73","vol":"33.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
46.17 | 47.30 | 47.46 | 47.03 | 47.73 |
| 行业(%) | 33.92 | 34.04 | 34.34 | 33.02 | 33.19 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.40","vol":"0.89"},{"date":"2025-03-31","value":"1.48","vol":"1.46"},{"date":"2024-12-31","value":"1.50","vol":"0.84"},{"date":"2024-09-30","value":"1.45","vol":"0.73"},{"date":"2024-06-30","value":"1.49","vol":"0.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.40 | 1.48 | 1.50 | 1.45 | 1.49 |
| 行业(%) | 0.89 | 1.46 | 0.84 | 0.73 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"6.68","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.33","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.02","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.99","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]